Orthofix sees $27.4M net loss in Q3: 6 notes

Spinal Tech

Orthofix saw a 7% year-over-year increase in net sales during the third quarter of 2024, according to financial results posted Nov. 7.

Six things to know:

1. Net sales were $196.6 million.

2. U.S. spinal fixation sales grew 18% year over year, and U.S. orthopedic sales grew 15% year over year.

3. The company entered a record number of 7D Flash navigation system earnout agreements and matched its record for the most 7D placements in any quarter to date.

4. Orthofix reported free cash flow of $5.9 million but also saw a net loss of $27.4 million.

5. Orthofix is maintaining its full-year sales trajectory of $795 million to $800 million.

6. There are also three new financial targets for 2025 through 2027: 6% to 7% net sales growth, mid-teens non-GAAP adjusted EBITDA and positive free cash flow generation.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers